Atai Life Sciences Total Liabilities 2020-2025 | ATAI

Atai Life Sciences total liabilities from 2020 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
Atai Life Sciences Annual Total Liabilities
(Millions of US $)
2024 $43
2023 $49
2022 $40
2021 $28
2020 $16
2019 $2
Atai Life Sciences Quarterly Total Liabilities
(Millions of US $)
2025-03-31 $44
2024-12-31 $43
2024-09-30 $51
2024-06-30 $47
2024-03-31 $46
2023-12-31 $49
2023-09-30 $40
2023-06-30 $38
2023-03-31 $40
2022-12-31 $40
2022-09-30 $47
2022-06-30 $29
2022-03-31 $29
2021-12-31 $28
2021-09-30 $21
2021-06-30 $21
2021-03-31 $25
2020-12-31 $16
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $2
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.749B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.222B 18.36
DaVita (DVA) United States $10.930B 15.37
Encompass Health (EHC) United States $10.798B 22.89
Elanco Animal Health (ELAN) United States $7.296B 15.63
Chemed (CHE) United States $6.774B 21.29
Option Care Health (OPCH) United States $4.826B 21.51
RadNet (RDNT) United States $4.201B 266.62
Amedisys (AMED) United States $3.211B 21.60
Addus HomeCare (ADUS) United States $1.990B 21.85
LifeStance Health (LFST) United States $1.610B 0.00
Astrana Health (ASTH) United States $1.261B 31.24
U.S Physical Therapy (USPH) United States $1.129B 29.15
Pennant (PNTG) United States $0.796B 29.24
Aveanna Healthcare Holdings (AVAH) United States $0.769B 43.78
Daxor (DXR) United States $0.048B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.037B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00